Document is current

Any future updates will be listed below

Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects

Crossref DOI link: https://doi.org/10.1007/s40261-014-0248-4

Published Online: 2014-11-19

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark